S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

NCT00064337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma
Plasma Cell Myeloma

Interventions

BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: melphalan
DRUG: thalidomide
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]